BCL2 and medulloblastoma: Most GEMMs of Group 3 medulloblastoma were developed by targeting myc. Newborn mice with myc overexpression in the cerebellum through the RCAS/TVA system induced Group 3 medulloblastoma, but tumor formation required tp53 loss or bcl-2 overexpression (81).